Psyence Biomedical (PBM) Assets Average (2023 - 2026)

Psyence Biomedical's Assets Average history runs 4 years deep, the most recent figure standing at $15.2 million for Q1 2026.

• On a quarterly basis, Assets Average rose 217.43% year-over-year to $15.2 million in Q1 2026; TTM through Mar 2026 was $15.2 million, a 217.43% increase from a year earlier, with the FY2026 full-year figure at $12.4 million, up 194.53% from the prior year.
• Assets Average rose to $15.2 million in Q1 2026 per PBM's latest filing, from $10.1 million in the prior quarter.
• Across five years, Assets Average topped out at $15.2 million in Q1 2026 and bottomed at $566085.8 in Q1 2024.
• The 4-year median for Assets Average is $3.2 million (2024), against an average of $5.5 million.
• Across the five-year window, Assets Average soared 112.9% in 2024 and jumped 745.27% in 2025, its largest moves.
• Year by year, Assets Average stood at $795133.8 in 2023, then surged by 112.9% to $1.7 million in 2024, then soared by 494.46% to $10.1 million in 2025, then jumped by 50.93% to $15.2 million in 2026.
• Per Business Quant, the three latest PBM Assets Average figures stand at $15.2 million (Q1 2026), $10.1 million (Q3 2025), and $4.8 million (Q1 2025).